Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NovaTears + Omega-3 is a water-free eye drop solution that combines perfluorohexyloctane with high-quality, concentrated omega-3 fatty acids (0.2%) of plant-based origin. It is designed to treat evaporative dry eye disease (DED) by stabilizing the lipid layer of the tear film, reducing tear evaporation, and providing anti-inflammatory benefits. The formulation lubricates and protects the corneal surface, relieving symptoms such as burning, itching, stinging, and foreign body sensation. Clinical studies have shown significant improvements in various clinical signs including total corneal staining, tear film break-up time, and Meibomian gland dysfunction score.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on perfluorohexyloctane + omega-3 fatty acids.